Diabetics ask not to restrict reactive strips

06/20/2010 8:29 a.m.

Bernat Soria considers that with "good prediction and prevention" you could "stop diabetes before the situation is serious"

Diabetes patients of the Valencian Community today demanded the Ministry of Health that "the distribution of reactive strips" is not restricted, while this Department of the Generalitat said that doctors "are free to prescribe what they consider appropriate" and how soOnly new recommendations have been established for proper use. "

These statements took place today after the Conference 'Current Diabetes Situation in the Valencian Community and in Spain', organized in Valencia by the Federation of Spanish Diabetics (Fede) and its Valencian homologous Fecova.

In the act, moderated by the president of Fecova, Mercedes Sánchez, the researcher and former Minister of Health and Consumption Bernat Soria were present;the Undersecretary of the Department of Health, Alfonos Bataller;the president of Fede, Ángel Cabrera;and the educator in diabetes Lola Abellán.

The initiative of this conference arose following the publication by the Valencian Association of Diabetes (AVD) of the Manual Adequate Use of the Blood Glucose Reactive Strgues in Patients with Diabetes, who, according to those affected, "tells doctorsDo not prescribe reactive strips to save ", while for Bataller" the guide aims to guide professionals and the sick, but each doctor has to prescribe a thing to each patient. "

In this sense, the Undersecretary said that "the entire health network is diabetes" and said that the Generalitat allocates 51.5 million euros a year, 44 million in insulin and 35 in oral antidiabetics.

For his part, Bernat Soria said that "not all strips serve everything, because each detects characteristics."Therefore, he insisted on "the importance of personalized medicine", because it is a "complex heterogeneous pathology, there are many ways to suffer from it, as many as patients, and not everyone has to take care of the same way."

The researcher said that if there is "good prediction and prevention, diabetes could be stopped before the situation is serious and can no longer go back."In this way, Soria stressed that it is a "global disease, which affects everyone" and pointed out that the control of the patients of their blood glymia "is the most effective and cheap method to avoid complications ofDiabetes ".

For his part, Cabrera stressed that the patient must be "the central axis of the health system" so his opinion "must be taken into account.""No one can tell the doctor where to cut. If we do not give the necessary material we can do beastly damage," he added.The president of Fede also said that reactive strips "only accounts for 0.6 percent of the health expenditure, while hospitalization represents 32 percent."

For his part, Lola Abellán said that the recommendations of said guide and the Diabetes Plan of the Generalitat "contradict them."In addition, in his opinion, the manual's instructions "can make the doctors afraid of not meeting the objectives set."In this sense, Abellán expressed his desire that "everything is an error and that when the diabetics return to their health centers they receive the strips without problems."

"Inadequate use"

Likewise, the president of the Valencian Society of Endocrinology, Diabetes and Nutrition, Carlos Sánchez Juan, one of the authors of the guide, said that the reactive strips "suffer inappropriate use for years."However, he said that the manual "does not restrict anything, there has been a more or less interested manipulation or bad information todoctors from the Ministry. "

All participants in the talk agreed to point out "the importance of education on patient diabetes, which has to know how to take care of themselves, and the professionals who attend them."In this sense, Bataller stressed that 47 percent of the Diabetics of the Community "do not know they are."

Bernat Soria also pointed out that "we must work so that diabetes is on the agenda of governments and is a goal."In this regard, he pointed out that the disease "is not right -wing or left."On the other hand, among the future perspectives for the disease, Soria explained, in addition to prediction and prevention, substitute cell therapy, pancreatic regeneration and the development of artificial pancreas.

"Every ten seconds one person dies for diabetes"

"In ten years diabetes has increased more quickly than we expected, but being diabetic should not be a limitation in personal or work life," said Soria, who added that "every ten seconds a person dies from diabetes. It is adisease that consumes much of the health budget ", so, in your opinion" you have to control it. "

In this regard, the Undersecretary of Health highlighted the campaign 'No diabetic without seeing', with which retinographers are going to be taken to the municipalities far from urban nuclei to detect vision problems in the patients, and also referred to the Diabetes Planof the Consell.

fer
06/20/2010 8:29 a.m.

@fer - Diabetes Tipo 1 desde 1.998 | FreeStyle Libre 3 | Ypsomed mylife YpsoPump + CamAPS FX | Sin complicaciones. Miembro del equipo de moderación del foro.
Co-Autor de Vivir con Diabetes: El poder de la comunidad online, parte de los ingresos se destinan a financiar el foro de diabetes y mantener la comunidad online activa.

Trench of one site ... now another ...: Shock ::
<!

Let's ask society what role the pharmaceutical industry should play, ”says Bernat Soria

Silvia C. Carpallo

On the occasion of the 60th anniversary of the presence of Abbott in Spain, the former minister will direct a report, in which the opinions of patients, health, researchers and politicians about his vision regarding the role of the pharmaceutical industry will be requested

Madrid (22-6-10) .- Abbott turns 60 years of presence in Spain, and for this reason he wanted to perform some action that marks a milestone within Spanish health.For thisPharmaceutical to guarantee the quality of the SNS and contribute to its sustainability."We are going to ask society what role the pharmaceutical industry should play," explained the professor.In this way Soria himself defined the project as "an expert report, but an actors report", to which he added that "this report does not seek to stay in a drawer, but seeks debate and dissemination."

For his part, Esteban Plata, president and CEO of Abbott, explained what was the role that the laboratory was going to play in the production of this report."Our role is exclusively to stimulate that this debate takes place, we are facilitated: from the scientific point of view, an enzyme that will help this exchange of opinions take place."

On the "who" of this project, in the first place we must address who will be responsible for its elaboration.In this way, if the director will be Bernat Soria himself, who will help coordinate discussions and interaction between the different participants will be the journalist Olga Viza, due to his renowned professional career.

In this regard, the former Minister of Health recognized that "I have a total level of autonomy to work."On the project methodology, Soria explained that "the idea is to work with all the actors, we will start with patient associations."

The report plans to have the collaboration of doctors, nursing, pharmacy, researchers, media, and of course also people from the political sphere, such as parliamentarians themselves. ”This integration document cannot leave out thecurrent actors and possible futures, and that means more than 50 direct interlocutors, ”says Soria, which also adds that he will contact the highest level actors, that is, presidents of patient associations, scientific associations andProfessionals, etc., to give more relevance to this document and to involve to a greater extent all the agents involved.

Conclusions in January 2011
The methodology that is proposed to be used in this report is to collect the opinions of the different agents, through group meetings or personal interviews.Thus, the director of the report assured that "I hope everything is, any issue that any of the actors consider is going to be treated."

The former minister did not assess which could be exactly the issues to be addressed or what could be the deficits that the groups appreciate within the pharmaceutical industry, but still did not rule out issues such as sustainability, co -responsibility in the SNS, the treatment ofrare diseases and of course the copayment.Thus the first meeting with thePatient associations will take place in July, and will continue to collect information until the end of the year, when the study is expected to conclude the conclusions in January 2011.

On the subject of how the 'Tijeretazo' of the Government will affect the pharmaceutical industry, both Esteban Plata and Bernat Soria explained that the initiative was forged prior to this fact, and that obviously they met to evaluate the situation in the face of the radical change of scenariothat had originated.Initially they acknowledged to shuffle the option to leave the project, since it could lead to conclusions and erroneous interpretations that were not the ones that had originally raised.Finally, the decision was to continue, since precisely this circumstance made its conclusions even more interesting.

Precisely on the final conclusions those in charge of the report stated that the idea is to include a series of final recommendations for improvement, but that everything will depend on how the document is developed and what are the information that ends up compiling in this regard.

Diabetics ask not to restrict reactive strips

Join the Discussion!